Paul Tudor Jones Revolution Medicines, Inc. Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 35,185 shares of RVMD stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,185Holding current value
$1.9 Million% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding RVMD
# of Institutions
334Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$851 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$774 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$724 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$572 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$554 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.74B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...